BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34209132)

  • 1. Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment.
    McGinity CL; Palmieri EM; Somasundaram V; Bhattacharyya DD; Ridnour LA; Cheng RYS; Ryan AE; Glynn SA; Thomas DD; Miranda KM; Anderson SK; Lockett SJ; McVicar DW; Wink DA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eph Receptors in the Immunosuppressive Tumor Microenvironment.
    Janes PW; Vail ME; Ernst M; Scott AM
    Cancer Res; 2021 Feb; 81(4):801-805. PubMed ID: 33177063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says "NO" to antitumor immune response.
    PeÑarando J; Aranda E; RodrÍguez-Ariza A
    Transl Res; 2019 Aug; 210():99-108. PubMed ID: 30953610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
    Mierke CT
    Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review).
    Li X; Xu W
    Oncol Rep; 2019 May; 41(5):2945-2956. PubMed ID: 30864716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunometabolism in cancer at a glance.
    Singer K; Cheng WC; Kreutz M; Ho PC; Siska PJ
    Dis Model Mech; 2018 Aug; 11(8):. PubMed ID: 30076128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolites in the Tumor Microenvironment Reprogram Functions of Immune Effector Cells Through Epigenetic Modifications.
    Li Y; Wu Y; Hu Y
    Front Immunol; 2021; 12():641883. PubMed ID: 33927716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immune Consequences of Lactate in the Tumor Microenvironment.
    Harmon C; O'Farrelly C; Robinson MW
    Adv Exp Med Biol; 2020; 1259():113-124. PubMed ID: 32578174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
    Pacella I; Piconese S
    Front Immunol; 2019; 10():1889. PubMed ID: 31507585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One microenvironment does not fit all: heterogeneity beyond cancer cells.
    Kim IS; Zhang XH
    Cancer Metastasis Rev; 2016 Dec; 35(4):601-629. PubMed ID: 27858305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.
    Agresta L; Hoebe KHN; Janssen EM
    Front Immunol; 2018; 9():2809. PubMed ID: 30546369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy.
    Sheppard AD; Lysaght J
    Methods Mol Biol; 2020; 2184():233-263. PubMed ID: 32808230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic axis of macrophage and immune cell polarization.
    Hobson-Gutierrez SA; Carmona-Fontaine C
    Dis Model Mech; 2018 Jul; 11(8):. PubMed ID: 29991530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and tumor metabolic reprogramming.
    López-Sánchez LM; Aranda E; Rodríguez-Ariza A
    Biochem Pharmacol; 2020 Jun; 176():113769. PubMed ID: 31862448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell: insight into remodeling a tumor microenvironment.
    Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
    Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.